CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.227
-0.004 (-1.73%)
At close: Mar 9, 2026

CytoDyn Ratios and Metrics

Millions USD. Fiscal year is Jun - May.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 May '25 May '24 May '23 May '22 May '21 2020 - 2016
Market Capitalization
2914271572392311,188
Upgrade
Market Cap Growth
-5.03%172.64%-34.59%3.83%-80.59%-22.02%
Upgrade
Enterprise Value
3134381862712661,213
Upgrade
Last Close Price
0.230.340.160.260.321.90
Upgrade
PE Ratio
-188.79----
Upgrade
PS Ratio
----867.10-
Upgrade
PB Ratio
-2.43-4.45-1.34-2.19-2.44-56.52
Upgrade
EV/Sales Ratio
----998.20-
Upgrade
EV/EBITDA Ratio
-45.25----
Upgrade
EV/EBIT Ratio
-45.33----
Upgrade
Debt / Equity Ratio
-0.23-0.28-0.26-0.32-0.39-3.02
Upgrade
Debt / EBITDA Ratio
-2.80----
Upgrade
Net Debt / Equity Ratio
-0.19-0.16-0.23-0.30-0.34-1.40
Upgrade
Net Debt / EBITDA Ratio
-1.171.60-1.50-0.82-0.22-0.32
Upgrade
Net Debt / FCF Ratio
-1.28-1.76-2.45-1.31-0.42-0.25
Upgrade
Asset Turnover
----0.00-
Upgrade
Quick Ratio
0.060.200.040.020.030.22
Upgrade
Current Ratio
0.100.250.130.090.090.24
Upgrade
Return on Assets (ROA)
-70.67%41.38%-100.64%-125.31%-112.71%-64.72%
Upgrade
Return on Capital Employed (ROCE)
25.10%-18.40%24.70%37.40%154.70%462.00%
Upgrade
Earnings Yield
-13.87%0.88%-31.82%-33.33%-91.40%-14.85%
Upgrade
FCF Yield
--2.05%-7.01%-10.48%-33.70%-9.91%
Upgrade
Buyback Yield / Dilution
-14.45%-28.20%-15.90%-23.58%-15.20%-39.54%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.